ImClone Systems
440 Route 22 East
Bridgewater
New Jersey
08807
United States
Tel: 908-541-8000
Website: http://www.imclone.com/
About ImClone Systems
ImClone Systems is a wholly-owned subsidiary of Eli Lilly and Company and part of Lilly’s oncology business unit. Dedicated to changing the world of cancer care, ImClone is developing its robust pipeline of novel monoclonal antibodies to treat a broad range of tumor types. ImClone is headquartered in New Jersey, where it has one of the world’s largest state-of-the-art biologics manufacturing operations, and it has research laboratories in New York City as well as offices in Europe.261 articles about ImClone Systems
-
In what is likely a preemptive move to avoid government action on insulin prices, Eli Lilly announced it will start selling an “authorized generic” version of Humalog 100 at about 50 percent off the list prices.
-
Convicted ImClone Systems Boss Becomes Chief Of Innovation At Kadmon Corporation While Brother Harlan W. Waksal, M.D Takes CEO Post
9/26/2014
-
Zymeworks Announces Strategic Collaboration With Eli Lilly and Company Subsidiary ImClone Systems To Develop Bi-specific Antibodies Using Zymeworks' Azymetric™ Platform
1/9/2014
-
Third Rock Ventures Taps Alnylam Pharmaceuticals CEO, Genzyme Corporation-ImClone Systems Vets, as Venture Partners
5/14/2013
-
Circadian Technologies Limited's Partner ImClone Systems Corporation Commences First Phase 1 Clinical Trial of VEGFR-3 Antibody IMC-3C5
4/6/2011
-
Eli Lilly and Company Announces New Vice President of Oncology Research for ImClone Systems Corporation
3/10/2011
-
ImClone Systems Corporation Ex-Chief Embarks on New Biotech Venture, Kadmon Pharmaceuticals
11/1/2010
-
ImClone Systems Corporation Manufacturing Facility Shutting Down, 140 People Affected
8/24/2010
-
Molecular Templates Inc. and ImClone Systems Corporation Form Oncology Drug Discovery and Translation Research Collaboration
7/6/2010
-
Eli Lilly and Company's ImClone Systems Corporation Chops Drug Safety Jobs
4/22/2010
-
ImClone Systems Corporation Founder Waksal Forming New Biotech Venture
2/16/2010
-
DxS Ltd Enters Into Collaboration With Bristol-Myers Squibb Company And ImClone Systems Incorporated To Provide a K-RAS Companion Diagnostic For ERBITUX(R)
9/2/2009
-
Eli Lilly and Company and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs; ImClone Systems Incorporated to Locate Resea
7/23/2009
-
ImClone Systems Incorporated (JOBS) and Bristol-Myers Squibb Company Announce Revisions to ERBITUX® (cetuximab) U.S. Product Labeling for Metastatic Colorectal Cancer
7/20/2009
-
Level 3 Expands Relationship with ImClone Systems Incorporated
6/29/2009
-
ImClone Systems Incorporated And Bristol-Myers Squibb Company Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
3/2/2009
-
Adding ImClone Systems Incorporated's Erbitux To Colon Cancer Drug Mix Not Helpful, Radboud University Nijmegen Medical Center Study
2/5/2009
-
Eli Lilly and Company Profit Falls on ImClone Systems Incorporated Charges
1/29/2009
-
ImClone Systems Incorporated and Bristol-Myers Squibb Company Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
1/26/2009
-
ImClone Systems Incorporated, Bristol-Myers Squibb Company Withdraw FDA Application
1/23/2009